The Kruppel-like factor 4 transcription factor has been shown to repress DYRK2 expression, acting directly on the DYRK2 promoter in chronic myeloid leukemia (CML) cell lines and mouse models, thereby favoring tumor progression [149]. This evidence concerns the gene DYRK2 and chronic myelogenous leukemia, BCR-ABL1 positive.